ERX - A thread for everyone

"EiRx stands to earn milestones and royalties on the successful development of ZYC300. A similar success-based milestone arrangement pertains to the Company's licensing of drug targets to OSI Pharmaceuticals (NASDAQ: OSIP). The Board will update the market if and when such milestones are reached".

This statement is correct but only when the ZYC300 hits the consumer market. The pre-clinical milestone payments which the Daily express and this thread have been expectant upon are two to three years of research and development away. The forthcoming placing will have to be at a substantial discount. Take your cash and wait to see how matters develop.